T. Rowe Price Associates’s Everus Construction Group ECG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57M Buy
343,681
+295,614
+615% +$43.3M 0.01% 852
2026
Q1
$5.67M Buy
48,067
+6,285
+15% +$650K ﹤0.01% 1381
2025
Q4
$3.58M Buy
41,782
+2,021
+5% +$181K ﹤0.01% 1509
2025
Q3
$3.41M Buy
39,761
+3,393
+9% +$252K ﹤0.01% 1518
2025
Q2
$2.31M Buy
36,368
+612
+2% +$31K ﹤0.01% 1578
2025
Q1
$1.33M Buy
35,756
+3,421
+11% +$184K ﹤0.01% 1806
2024
Q4
$2.13M Buy
+32,335
New +$2.03M ﹤0.01% 1616

Other funds holding ECG

T. Rowe Price Associates's ECG Position: Q2 2026 in Review

T. Rowe Price Associates increased its Everus Construction Group (ECG) stake by 615% in Q2 2026, buying an estimated $43.3M and bringing the position to 343,681 shares worth $57M. The position accounts for 0.01% of the portfolio, ranked #852.

T. Rowe Price Associates first reported a position in ECG in Q4 2024 and has held it in 7 quarters since. 539 funds tracked by Wall St. Rank hold ECG as of Q2 2026.

  • T. Rowe Price Associates held 343,681 shares of Everus Construction Group worth $57M as of Q2 2026.
  • T. Rowe Price Associates bought 295,614 Everus Construction Group shares in Q2 2026, an estimated $43.3M.
  • Everus Construction Group made up 0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #852 holding.
  • T. Rowe Price Associates first reported a position in Everus Construction Group in Q4 2024 and has held it in 7 quarters since.
  • 539 funds tracked by Wall St. Rank held Everus Construction Group as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.